US › Healthcare

Microbot Medical Inc (MBOT)

US · Healthcare · Medical Devices

$1.42-1.39%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$241,000

Net profit

$-5.6M

EPS

$-0.08

EPS estimate

$-0.08

Net margin

-2,334.9%

EPS came in at -0.08 against a street estimate of -0.08 — a beat of 0.0%.

Key statistics

Market cap

$97.4M

Forward P/E

31.7

P/B

1.41

Book value

$1.03

EPS (TTM)

$-0.25

52-week high

$3.75

52-week low

$1.44

50-day MA

$1.68

200-day MA

$2.03

Beta

1.03

Analyst view

Analysts rate Microbot Medical Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.67.

Shareholding

Institutions

17.41%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	4.33%
CIBC Bancorp USA Inc.	2.78%
Susquehanna International Group, LLP	1.38%
BlackRock Inc	1.28%
UBS Group AG	1.22%
Geode Capital Management, LLC	1.13%
DnB NOR Asset Management (Asia)	1.01%
Stifel Financial Corp	0.85%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Microbot Medical Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.